Alan Kozikowski
No más puestos en curso
Fortuna: 436 545 $ al 30/04/2024
Perfil
Alan P.
Kozikowski was the founder of Actuate Therapeutics, Inc. (founded in 2015) and Bright Minds Biosciences, Inc. (founded in 2019), where he held the title of Director in 2022.
He was the President & Chief Executive Officer of Starwise Therapeutics LLC from 2017 to 2020.
He also held the title of Director-Drug Discovery Program at Georgetown University Medical Center and was a Professor at the University of Pittsburgh.
From 2013 to 2017, he was a Professor-Emeritus at the University of Illinois.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/12/2023 | 400 500 ( 9.27% ) | 436 545 $ | 30/04/2024 |
Antiguos cargos conocidos de Alan Kozikowski.
| Empresas | Cargo | Fin |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Fundador | 07/09/2022 |
| Starwise Therapeutics LLC | Director Ejecutivo | 01/02/2020 |
| University of Illinois | Corporate Officer/Principal | 31/07/2017 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Fundador | - |
| Georgetown University Medical Center | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
| Starwise Therapeutics LLC |
- Bolsa de valores
- Insiders
- Alan Kozikowski